3808-42-2 Usage
Description
Streptothricin F is a member of the streptothricin family, which are a group of aminoglycoside-type antibiotics. It is characterized by a peptide side-chain consisting of a single unit of beta-lysine. This unique structure contributes to its potential antimicrobial properties and makes it a candidate for pharmaceutical applications.
Uses
Used in Pharmaceutical Industry:
Streptothricin F is used as an antibiotic agent for its antimicrobial properties. It is particularly effective against a range of bacteria, including both Gram-positive and Gram-negative strains. Its unique structure allows it to target specific bacterial components, inhibiting their growth and contributing to the treatment of various infections.
Additionally, due to its aminoglycoside nature, streptothricin F may be used in combination with other antibiotics to enhance their efficacy and combat antibiotic resistance. This application can be particularly valuable in the development of new antimicrobial therapies to address the growing global health concern of antibiotic resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 3808-42-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,8,0 and 8 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3808-42:
(6*3)+(5*8)+(4*0)+(3*8)+(2*4)+(1*2)=92
92 % 10 = 2
So 3808-42-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H34N8O8/c20-3-1-2-7(21)4-10(30)24-13-14(31)15(35-18(22)33)9(6-28)34-17(13)27-19-25-11-8(29)5-23-16(32)12(11)26-19/h7-9,11-15,17,28-29,31H,1-6,20-21H2,(H2,22,33)(H,23,32)(H,24,30)(H2,25,26,27)/t7?,8-,9-,11-,12+,13-,14+,15+,17-/m1/s1
3808-42-2Relevant articles and documents
TOTAL SYNTHESIS OF ANTIBIOTIC STREPTOTHRICIN F
Kusumoto, Shoichi,Imaoka, Susumu,Kambayashi, Yoshikazu,Shiba, Tetsuo
, p. 2961 - 2964 (2007/10/02)
The first total synthesis of streptothricin F was achieved and its structure was unequivocally confirmed.